NYU Langone Hospital-Long Island is a clinical research site located in Mineola, New York, United States 11501.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
NYU Langone Hospital-Long Island has participated in 7 clinical trials with 4 currently active.
Therapeutic areas: Prader-Willi Syndrome, Breast Cancer, Pressure Ulcers Stage II.
Sponsors: Gedeon Richter Plc., Stemline Therapeutics, Inc., ULURU Inc..
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
NYU Langone Hospital-Long Island has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NYU Langone Hospital-Long Island has 7 clinical trials on record, with 4 currently active. Their work covers Prader-Willi Syndrome, Breast Cancer, Pressure Ulcers Stage II.
Yes — NYU Langone Hospital-Long Island holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.